Zn2+ complexation significantly enhanced the antiproliferative activity and cytotoxicity of tetracycline in non-small cell lung cancer A549 cells compared to the free ligand.
Does Zn2+ complexation enhance the antiproliferative activity of tetracycline in non-small cell lung cancer cells?
Zn2+ complexation enhances the in vitro antiproliferative activity of tetracycline in non-small cell lung cancer cells.
High Resolution Image Download MS PowerPoint Slide Tetracycline (TC), the primary member of the tetracyclines, is a widely used broad-spectrum antibiotic that has also attracted interest for its nonantibiotic biological effects, including anticancer activity. The aim of this study is to assess the acid–base behavior of TC, its ability to form complexes with Zn 2+ under various conditions, and to demonstrate that such species enhance the antitumor activity of TC in non-small cells lung cancer (NSCLC). The speciation study on TC and its Zn 2+ complexes was performed in aqueous NaCl solutions at different temperatures (15 ≤ t/ °C ≤ 45) and I = 0.15 mol L –1 via potentiometric, UV–vis spectrophotometric, and 1 H NMR titrations. The protonation and formation constants of the species were calculated, and their temperature dependence was evaluated, along with the sequestration capacity of TC toward Zn 2+ . The speciation results were essential to identify the most suitable Zn 2+ /TC ratio and experimental conditions to ensure significant complex formation for the in vitro cytotoxicity studies in A549 cells. The biological results showed that Zn 2+ complexation significantly affected the cytotoxicity of TC, enhancing its antiproliferative activity compared to the free ligand.
Abate et al. (Thu,) conducted a other in Non-small cell lung cancer (NSCLC). Zn2+ complexation with Tetracycline vs. Free Tetracycline ligand was evaluated on Antiproliferative activity and cytotoxicity in A549 cells. Zn2+ complexation significantly enhanced the antiproliferative activity and cytotoxicity of tetracycline in non-small cell lung cancer A549 cells compared to the free ligand.